国际麻醉学与复苏杂志   2014, Issue (3): 8-8
    
右美托咪定在镇痛中的研究进展
刘清仁, 季永1()
1.无锡锡山人民医院
Advances in Analgesia Use of Dexmedetomidine
 全文:
摘要:

摘要:背景 右美托咪定(dexmedetomidine,Dex)是一种新型高选择性α2肾上腺素能受体激动剂,具有镇静、镇痛、抗焦虑及抗交感等作用,因此能明显减少围术期麻醉药用量,有效缓解应激反应,促进血流动力学稳定及降低术后疼痛反应,以至于提高患者围术期的舒适度。目的 对有关Dex的论著进行归纳总结,阐述其在镇痛方面的应用进展。内容 概述了Dex的镇痛作用机制,并探讨其在围术期镇痛、ICU镇痛及门诊镇痛的临床应用。趋向 Dex的镇痛作用机制目前尚未完全研究清楚,但目前其在疼痛方面的应用已日益广泛。

关键词: 关键词:α2受体激动剂;右美托咪定;镇痛
Abstract:

Abstract: Background Dexmedetomidine is a novel and highly selective a2-adrenoceptor agonist with sedative, analgesic, anxiolytic and antisympathetic properties. It can reduce the requirements of perioperative anesthetics,attenuate stress reaction,promote hemodynamics stable and alleviate postoperative pain, then improve perioperative comfort of patient. Objective Summarize the relevant studies and conduct a review on advances in analgesia use of dexmedetomidine. Content Account the analgesia mechanisms of dexmedetomidine and discuss its clinical application for analgesia in perioperation, ICU and outpatient. Trend The analgesia mechanism of dexmedetomidine is still unclear, but it has been more and more widely used in analgesia.

Key words: Keywords: a2-adrenoceptor agonist; Dexmedetomidine; analgesia